TLRY
Price
$2.47
Change
-$0.01 (-0.40%)
Updated
Mar 28, 6:59 PM EST
11 days until earnings call
ZOM
Price
$0.15
Change
+$0.01 (+7.14%)
Updated
Mar 28, 6:59 PM EST
3 days until earnings call
Ad is loading...

Compare predictions TLRY vs ZOM

Header iconTLRY vs ZOM Comparison
Open Charts TLRY vs ZOMBanner chart's image
Tilray Brands
Price$2.47
Change-$0.01 (-0.40%)
Volume$29.97M
CapitalizationN/A
Zomedica
Price$0.15
Change+$0.01 (+7.14%)
Volume$3.35M
CapitalizationN/A
View a ticker or compare two or three
TLRY vs ZOM Comparison Chart

Loading...

TLRYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ZOMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
TLRY vs. ZOM commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TLRY is a StrongBuy and ZOM is a StrongBuy.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (TLRY: $2.47 vs. ZOM: $0.15)
Brand notoriety: TLRY: Notable vs. ZOM: Not notable
TLRY represents the Pharmaceuticals: Other, while ZOM is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: TLRY: 213% vs. ZOM: 112%
Market capitalization -- TLRY: $1.87B vs. ZOM: $142.97M
TLRY [@Pharmaceuticals: Other] is valued at $1.87B. ZOM’s [@Medical Specialties] market capitalization is $142.97M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $2.98B. The average market capitalization across the [@Medical Specialties] industry is $7.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TLRY’s FA Score shows that 0 FA rating(s) are green whileZOM’s FA Score has 1 green FA rating(s).

  • TLRY’s FA Score: 0 green, 5 red.
  • ZOM’s FA Score: 1 green, 4 red.
According to our system of comparison, both TLRY and ZOM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TLRY’s TA Score shows that 5 TA indicator(s) are bullish while ZOM’s TA Score has 5 bullish TA indicator(s).

  • TLRY’s TA Score: 5 bullish, 5 bearish.
  • ZOM’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ZOM is a better buy in the short-term than TLRY.

Price Growth

TLRY (@Pharmaceuticals: Other) experienced а +26.67% price change this week, while ZOM (@Medical Specialties) price change was +7.68% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +7.96%. For the same industry, the average monthly price growth was +4.60%, and the average quarterly price growth was +16.17%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.84%. For the same industry, the average monthly price growth was -0.26%, and the average quarterly price growth was +4.27%.

Reported Earning Dates

TLRY is expected to report earnings on Jul 24, 2024.

ZOM is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Pharmaceuticals: Other (+7.96% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (+0.84% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for TLRY with price predictions.
OPEN
A.I.dvisor published
a Summary for ZOM with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
TLRY($1.87B) has a higher market cap than ZOM($143M). TLRY YTD gains are higher at: 7.391 vs. ZOM (-27.123). ZOM has higher annual earnings (EBITDA): -11.94M vs. TLRY (-1.23B). TLRY has more cash in the bank: 260M vs. ZOM (106M). ZOM has less debt than TLRY: ZOM (1.75M) vs TLRY (529M). TLRY has higher revenues than ZOM: TLRY (700M) vs ZOM (24M).
TLRYZOMTLRY / ZOM
Capitalization1.87B143M1,304%
EBITDA-1.23B-11.94M10,337%
Gain YTD7.391-27.123-27%
P/E Ratio8.52N/A-
Revenue700M24M2,917%
Total Cash260M106M245%
Total Debt529M1.75M30,194%
FUNDAMENTALS RATINGS
ZOM: Fundamental Ratings
ZOM
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TLRYZOM
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 16 days ago
88%
Bearish Trend 11 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 4 days ago
84%
View a ticker or compare two or three
Ad is loading...
TLRYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ZOMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSIQX22.010.04
+0.18%
Goldman Sachs GQG Ptnrs Intl Opps R
RGNCX25.27N/A
N/A
Victory Global Energy Transition C
MLUZX12.27N/A
N/A
MassMutual Mid Cap Value I
JOEMX11.24N/A
N/A
JOHCM Emerging Markets Opps Instl
TIRHX17.11N/A
N/A
TIAA-CREF Real Estate Sec Advisor